Christine Pietsch

N-Heterocyclic 3-Pyridyl Carboxamide Inhibitors of DHODH for the Treatment of Acute Myelogenous Leukemia.

Colleen E. Keohane, J. Edwards, E. Jacoby, 2022, Journal of medicinal chemistry.

Abstract 90: Development of a systemic Kasumi-3 acute myeloid leukemia model in NSG mice

E. Kaiser, M. Lubomirski, F. McCabe, 2014 .

Abstract 1256: JNJ-74856665, a novel DHODH inhibitor, mediates potent anti-leukemic activity and differentiationin vitroandin vivo

E. Jacoby, T. Bush, S. Kuduk, 2021, Experimental and Molecular Therapeutics.

Nrf2 Mediates the Induction of Ferritin H in Response to Xenobiotics and Cancer Chemopreventive Dithiolethiones*

E. Pietsch, F. Torti, S. Torti, 2003, The Journal of Biological Chemistry.

Discovery of JNJ-74856665: A Novel Isoquinolinone DHODH Inhibitor for the Treatment of AML.

S. Kuduk, U. Philippar, Justin S Cisar, 2024, Journal of medicinal chemistry.

Pharmacological Characterization of JNJ-75276617, a Menin-KMT2A Inhibitor, As Targeted Treatment for KMT2A-Altered and NPM1-Mutant Acute Leukemia

Bie M. P. Verbist, U. Philippar, C. Drenberg, 2022, Blood.